Top-Rated StocksTop-RatedPositive News SentimentPositive NewsNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $9.63 -0.01 (-0.12%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$9.65 +0.03 (+0.27%) As of 08/29/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Evolent Health Stock (NYSE:EVH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Evolent Health alerts:Sign Up Key Stats Today's Range$9.48▼$9.8450-Day Range$8.71▼$11.8052-Week Range$7.06▼$32.35Volume1.37 million shsAverage Volume3.77 million shsMarket Capitalization$1.13 billionP/E RatioN/ADividend YieldN/APrice Target$18.07Consensus RatingBuy Company Overview Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. Read More Evolent Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreEVH MarketRank™: Evolent Health scored higher than 25% of companies evaluated by MarketBeat, and ranked 557th out of 656 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has only been the subject of 3 research reports in the past 90 days.Read more about Evolent Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Evolent Health are expected to decrease in the coming year, from $0.08 to ($0.29) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.27% of the float of Evolent Health has been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 7.Change versus previous monthShort interest in Evolent Health has recently increased by 7.29%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.27% of the float of Evolent Health has been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 7.Change versus previous monthShort interest in Evolent Health has recently increased by 7.29%, indicating that investor sentiment is decreasing significantly. News and Social Media2.5 / 5News Sentiment1.52 News SentimentEvolent Health has a news sentiment score of 1.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.01 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Evolent Health this week, compared to 7 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.60% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVH Stock News HeadlinesContrasting Evolent Health (NYSE:EVH) & eGain (NASDAQ:EGAN)August 29 at 2:19 AM | americanbankingnews.comFTAI Infrastructure, Acadia Healthcare, agilon health, Clover Health, and Evolent Health Shares Skyrocket, What You Need To KnowAugust 22, 2025 | msn.comThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...September 1 at 2:00 AM | Crypto 101 Media (Ad)Evolent Health Closes $166.75M Convertible Notes SaleAugust 21, 2025 | tipranks.comEvolent's Soft Q2 Results: Why I'm Holding AnywayAugust 21, 2025 | seekingalpha.comEvolent Health prices upsized $145M convertible senior note debtAugust 19, 2025 | msn.comEvolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145. ...August 19, 2025 | gurufocus.comEvolent Health prices convertible notes offeringAugust 19, 2025 | msn.comSee More Headlines EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $11.25 at the start of the year. Since then, EVH shares have decreased by 14.4% and is now trading at $9.6280. How were Evolent Health's earnings last quarter? Evolent Health, Inc (NYSE:EVH) announced its quarterly earnings results on Thursday, August, 7th. The technology company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of $0.10 by $0.20. The company's revenue was down 31.3% on a year-over-year basis. Read the conference call transcript. When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's top institutional investors include Durable Capital Partners LP (5.47%), Engaged Capital LLC (4.99%), William Blair Investment Management LLC (3.68%) and Eventide Asset Management LLC (3.48%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Cheryl Scott and Brendan B Springstubb. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Last Earnings8/07/2025Today9/01/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry INTERNET SOFTWARE Sub-IndustryBusiness Services Current SymbolNYSE:EVH CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,500Year FoundedN/APrice Target and Rating Average Price Target for Evolent Health$18.07 High Price Target$35.00 Low Price Target$12.00 Potential Upside/Downside+87.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($1.61) Trailing P/E RatioN/A Forward P/E Ratio120.35 P/E GrowthN/ANet Income-$61.62 million Net Margins-5.94% Pretax Margin-5.99% Return on Equity1.83% Return on Assets0.70% Debt Debt-to-Equity Ratio0.72 Current Ratio1.01 Quick Ratio1.01 Sales & Book Value Annual Sales$2.55 billion Price / Sales0.44 Cash Flow$1.51 per share Price / Cash Flow6.36 Book Value$8.70 per share Price / Book1.11Miscellaneous Outstanding Shares117,510,000Free Float115,629,000Market Cap$1.13 billion OptionableOptionable Beta0.73 Social Links 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:EVH) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.